XML 133 R63.htm IDEA: XBRL DOCUMENT v3.3.0.814
Discontinued Operations and Divestitures (Narrative) (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 25, 2015
Jun. 26, 2015
Mar. 27, 2015
Dec. 26, 2014
Sep. 26, 2014
Jun. 27, 2014
Mar. 28, 2014
Dec. 27, 2013
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Non-restructuring impairment charges                   $ 0 $ 151,600,000 $ 0
Provision for (benefit from) income taxes [1]                   92,900,000 10,100,000 (47,500,000)
Tax (benefit) expense on income (loss) from discontinued operations                   11,500,000 (34,700,000) 21,100,000
Permanently nondeductible and nontaxable items [2]                   16,400,000 13,800,000 15,300,000
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount                   21,500,000 32,100,000 10,000,000
Income (loss) from discontinued operations, net of income taxes   $ (14,800,000) $ 2,400,000 $ 23,600,000 $ 5,300,000 $ (178,900,000) $ 4,900,000 $ (8,600,000) $ 7,100,000 16,500,000 (175,500,000) 50,600,000
Gain on Divestiture                   3,500,000 15,000,000 2,900,000
International [1]                   95,100,000 17,900,000 12,100,000
International Deferred [1]                   (187,500,000) (19,200,000) 4,400,000
Deferred Income Tax Expense (Benefit) [1]                   (188,300,000) (68,900,000) (13,900,000)
Domestic [1]                   300,000 40,900,000 49,300,000
Contrast Media and Delivery Systems                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Consideration   270,000,000               270,000,000    
Non-restructuring impairment charges                     204,000,000  
Goodwill, Impairment Loss                     100,200,000  
Income tax expense (benefit)                   10,800,000 (34,700,000) 21,100,000
Taxes paid or to be paid in connection with disposition   $ 10,000,000               10,000,000    
Provision for (benefit from) income taxes                     36,200,000  
Valuation allowances, nonrecurring                     2,500,000  
Permanently nondeductible and nontaxable items                       2,900,000
Other Tax Expense (Benefit)                     2,000,000  
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount                     3,000,000 700,000
Increase (Decrease) in Accrued Liabilities                     900,000  
International                   14,900,000 (6,600,000) 10,700,000
International Deferred                   4,400,000 3,000,000 (500,000)
Deferred Income Tax Expense (Benefit)                     35,600,000 5,400,000
Domestic                   0 10,400,000 5,600,000
Mallinckrodt Baker                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Income (loss) from discontinued operations, net of income taxes                   (100,000) (700,000) $ 1,000,000
Tastemaker                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Provision for Loss (Gain) on Disposal, Net of Tax                   $ 22,500,000    
Property, Plant and Equipment | Contrast Media and Delivery Systems                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Impairment of Long-Lived Assets to be Disposed of                     51,400,000  
Finite-Lived Intangible Assets | Contrast Media and Delivery Systems                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Impairment of Long-Lived Assets to be Disposed of                     52,400,000  
Oxymorphone ER                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Proceeds from Sale of Productive Assets $ 4,000,000                      
Contractually Obligated Future Proceeds from Sale Of Productive Assets $ 8,000,000                      
Gain on Divestiture                     $ 11,700,000  
[1] Domestic reflects U.K. in fiscal 2015, and U.S. federal and state in fiscal 2014 and fiscal 2013.
[2] Includes the impact of nondeductible transaction and separation costs.